Delivery information of semidone tablet, a new drug of Xianju pharmaceutical

According to the website of the State Food and Drug Administration (CFDA) on June 4, the delivery information of semidone, a heavy-duty anti pregnancy drug, which was applied for production by Xianju pharmaceutical, appeared It is understood that the service information is the supplementary information to notify the company As a class 1.1 new drug in China, semidone tablet is a major special product The new drug, as the first one in China, belongs to the category of family planning drugs for gynecology It has the same use as mifepristone and is mainly used for drug abortion The research team hopes to overcome the shortcomings of "mifepristone", which is widely used in clinical abortion, such as incomplete abortion and large amount of bleeding Xianju pharmaceutical began to apply for clinical approval of the product in August 2003, and was approved in March 2004 In April 2013, Xianju pharmaceutical applied for production approval Shenyin Wanguo research report pointed out that Xianju pharmaceutical has a competitive product line in the field of contraceptives and skin diseases Mifepristone capsule and misoprostol, the emergency contraceptive, are jointly used as anti early pregnancy drugs, with a leading market share and a revenue scale of about 100 million in recent years Xianju pharmaceutical is mainly engaged in the pharmaceutical industry, mainly including corticosteroids, gynecological and family planning drugs, anesthesia and muscle relaxants According to the company's 2013 annual report, the research and development direction in the future also focuses on the above areas.